Skip to main content

The Neuroethics of Pleasure and Addiction in Public Health Strategies Moving Beyond Harm Reduction: Funding the Creation of Non-Addictive Drugs and Taxonomies of Pleasure

Neuroethics volume 4, pages 103–117 (2011)Cite this article

Abstract

We are unlikely to stop seeking pleasure, as this would prejudice our health and well-being. Yet many psychoactive substances providing pleasure are outlawed as illicit recreational drugs, despite the fact that only some of them are addictive to some people. Efforts to redress their prohibition, or to reform legislation so that penalties are proportionate to harm have largely failed. Yet, if choices over seeking pleasure are ethical insofar as they avoid harm to oneself or others, public health strategies should foster ethical choice by moving beyond current risk management practices embodied in the harm reduction movement. The neuroscience of pleasure has much to offer neuroethics and public health strategies. Distinguishing between ‘wanting’ and ‘liking’ fosters new understandings of addiction. These hold promise for directing the search for pharmacotherapies which prevent addiction and relapse or disrupt associated neuromechanisms. They could inform new research into creating lawful psychoactive substances which give us pleasure without provoking addiction. As the health and well being of human and other animals rests upon the experience of pleasure, this would be an ethical objective within public health strategy. Were ethical and neurobiological obstacles to ending addiction to be overcome, problems associated with excessive consumption, the lure of unlawful psychoactive substances and the paucity of lawful means to achieve pleasurable altered states would remain. Non-addictive designer drugs, which reliably provided lawful access to pleasures and altered states, would ameliorate these public health concerns insofar as they fostered citizens’ informed, ethical choices according to a neurobiological taxonomy of pleasures.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price includes VAT (USA)
Tax calculation will be finalised during checkout.

References

  1. Boland, P. 2008. British drugs policy: problematising the distinction between legal and illegal drugs and the definition of the ‘drugs problem’. Probation Journal 55: 171–187.

    Article  Google Scholar 

  2. Nutt, D. 2009. Estimating drug harms: a risky business? Briefing 10, October 2009. Centre for Crime and Justice Studies. London: Centre for Crime and Justice Studies. http://www.crimeandjustice.org.uk/estimatingdrugharmspr.html . Accessed 3 November 2009.

  3. RSA Commission. 2007. Drugs—facing facts: the report of the RSA Commission on illegal drugs, communities and public policy. London: Royal Society for the Encouragement of the Arts, Manufacture and Commerce (RSA).

    Google Scholar 

  4. Hall, W., and T.F. Babor. 2000. Editorial: cannabis use and public health: assessing the burden. Addiction 95: 485–490.

    Article  Google Scholar 

  5. Stephens, D.N., and T. Duka. 2008. Cognitive and emotional consequences of binge drinking: role of amygdala and prefrontal cortex. Philosophical Transactions of the Royal Society. Series B 363: 3169–3179.

    Article  Google Scholar 

  6. Hall, W. 2009. The adverse health effects of cannabis use: what are they, and what are the implications for policy? International Journal of Drug Policy 20: 458–465.

    Google Scholar 

  7. Edwards, G. 2004. Matters of substance: drugs—and why everyone’s a user. London: Allen Lane.

    Google Scholar 

  8. Hall, W., L. Carter, and K.I. Morley. 2004. Neuroscience research on the addictions: a prospectus for future ethical and policy analysis. Addictive Behaviors 29: 1481–1495.

    Article  Google Scholar 

  9. Lankenau, S., et al. 2008. Towards an explanation of subjective ketamine experiences of young injection drug users. Addiction Research & Theory 16: 273–287.

    Article  Google Scholar 

  10. Mackenzie, R. 2006. Addiction in public health and criminal justice system governance: neuroscience, enhancement and happiness research. Genomics, Society and Policy 2: 92–109.

    Google Scholar 

  11. Mackenzie, R. 2008. Feeling good: the ethopolitics of pleasure, psychoactive substance use and public health and criminal justice system governance: therapeutic jurisprudence and the drug courts in the United States of America. Social & Legal Studies 17: 513–533.

    Article  Google Scholar 

  12. Monaghan, M. 2008. Appreciating cannabis: the paradox of evidence in evidence-based policy making. Evidence and Policy 4: 209–231.

    Article  Google Scholar 

  13. Travis, A., and D. Summers. 2009. Alan Johnson orders snap review of drugs advice body. Guardian. http://www.guardian.co.uk/politics/2009/nov/02/drugspolicy-drugs/print . Accessed 2 November 2009.

  14. Frijda, N.H. 2010. On the nature and function of pleasure. In Pleasures of the brain, ed. M.L. Kringelbach and K.C. Berridge, 99–112. New York: Oxford University Press.

    Google Scholar 

  15. Degenhardt, L., W. Hall, and M. Lynskey. 2003. Exploring the association between cannabis use and depression. Addiction 98: 1493–1504.

    Article  Google Scholar 

  16. Stenbacka, M., and Leifman Anders. 2001. Can individual competence factors prevent adult substance and alcohol abuse in low and high income areas? Alcohol 25: 107–114.

    Article  Google Scholar 

  17. Iverson, L. 2007. Science and medical use of marijuana. Oxford: Oxford University Press.

    Book  Google Scholar 

  18. Leknes, S., and I. Tracey. 2010. Pain and pleasure: masters of mankind. In Pleasures of the brain, ed. M.L. Kringelbach and K.C. Berridge, 320–336. New York: Oxford University Press.

    Google Scholar 

  19. Berridge, K.C., and M.L. Kringelbach. 2008. Affective neuroscience of pleasure: reward in humans and animals. Psychopharmacology 199: 457–480.

    Article  Google Scholar 

  20. Kringelbach, M.L., and K.C. Berridge. 2009. Towards a functional neuroanatomy of pleasure and happiness. Trends in Cognitive Science 13: 479–487.

    Article  Google Scholar 

  21. Schroeder, T. 2004. Three faces of desire. New York: Oxford University Press.

    Google Scholar 

  22. Clark, R.E. 2009. Resistance to change: unconscious knowledge and the challenge of unlearning. In Changing institutions, environments and people, ed. D.C. Berliner and H. Kupwermintz, 75–94. New York: Routledge.

    Google Scholar 

  23. Kringelbach, M.L., and K.C. Berridge. 2010. Fundamental pleasure questions. In Pleasures of the brain, ed. M.L. Kringelbach and K.C. Berridge, 7–26. New York: Oxford University Press.

    Google Scholar 

  24. Cabanac, M. 2010. The dialectics of pleasure. In Pleasures of the brain, ed. M.L. Kringelbach and K.C. Berridge, 113–124. New York: Oxford University Press.

    Google Scholar 

  25. Berridge, K.C., T.E. Robinson, and J. Wayne Aldridge. 2009. Dissecting components of reward: ‘liking’, ‘wanting’ and learning. Current Opinion in Pharmacology 9: 65–73.

    Article  Google Scholar 

  26. Hyman, S.E., R.C. Malenka, and E.J. Nestler. 2006. Neural mechanisms of addiction: the role of reward-related learning and memory. Annual Review of Neuroscience 29: 565–598.

    Article  Google Scholar 

  27. Leyton, M. 2010. The neurobiology of desire: dopamine and the regulation of mood and motivational states in humans. In Pleasures of the brain, ed. M.L. Kringelbach and K.C. Berridge, 222–243. New York: Oxford University Press.

    Google Scholar 

  28. Figlewicz, D.P., and S.C. Benoit. 2009. Insulin, leptin and food reward: update 2008. American Journal of Physiological Regulation Integrating Comparative Physiology 296: R9–R19.

    Article  Google Scholar 

  29. Potenza, M.C. 2008. The neurobiology of pathological gambling and drug addiction: an overview and new findings. Philosophical Transactions of the Royal Society. Series B 363: 3181–3189.

    Article  Google Scholar 

  30. Volkow, N.D., et al. 2008. Overlapping neuronal circuits in addiction and obesity: evidence of systems pathology. Philosophical Transactions of the Royal Society. Series B 363: 3191–3200.

    Article  Google Scholar 

  31. Koob George, F., and N.D. Volkow. 2009. Neurocircuitry of addiction. Neuropharmacology Reviews. doi:np/npp.2009.110.

    Google Scholar 

  32. Koob, G.F., and M. Le Moal. 2008. Addiction and the brain anti-reward system. Annual Review of Psychology 59: 29–53.

    Article  Google Scholar 

  33. Everitt, B.J., et al. 2008. Neural mechanisms underlying the vulnerability to develop compulsive drug-seeking habits and addiction. Philosophical Transactions of the Royal Society. Series B 363: 3125–3135.

    Article  Google Scholar 

  34. Berridge, K.C. 2009. ‘Liking’ and ‘wanting’ food rewards: brain substrates and roles in eating disorders. Physiology & Behavior 97: 537–550.

    Article  Google Scholar 

  35. Berridge, K.C. 2007. The debate over dopamine’s role in reward: the case for incentive salience. Psychopharacology 191: 391–431.

    Article  Google Scholar 

  36. Berridge, K.C., and T.E. Robinson. 2003. Parsing reward. Trends in Neurosciences 26: 507–513.

    Article  Google Scholar 

  37. Kowe, M.R., and M.L. Butryn. 2007. Hedonic humger: a new dimension of appetite? Physiology & Behavior 91: 432–439.

    Article  Google Scholar 

  38. Kringelbach, M.L. 2010. The hedonic brain: a functional neuroanatomy of human pleasure. In Pleasures of the brain, ed. M.L. Kringelbach and K.C. Berridge, 202–221. New York: Oxford University Press.

    Google Scholar 

  39. Kringelbach, M.L. 2005. The orbitofrontal cortex: linking reward to hedonic experience. Nature Reviews Neuroscience 6: 691–702.

    Article  Google Scholar 

  40. Robinson, T.E., and K.C. Berridge. 2008. The incentive sensitisation theory of addiction: some current issues. Philosophical Transactions of the Royal Society. Series B 363: 3137–3146.

    Article  Google Scholar 

  41. Quartz, S.R. 2009. Reason, emotion and decision-making: risk and reward computation with feeling. Trends in Cognitive Science 13: 209–216.

    Article  Google Scholar 

  42. Shubin, N. 2008. Your inner fish: a journey into the 3.5-billion-year history of the human body. London: Allen Lane.

    Google Scholar 

  43. Chiara, G.C., and V. Bassareo. 2006. Reward system and addiction: what dopamine does and doesn’t do. Current Opinion in Pharmacology 7: 69–75.

    Google Scholar 

  44. Lowe, M.R., and M.L. Butryn. 2007. Hedonic hunger: a new dimension of appetite. Physiology & Behavior 91: 432–439.

    Article  Google Scholar 

  45. Avena, N.M., P. Rada, and B.C. Hoebel. 2009. Sugar and fat bingeing have notable differences in addictive-like behaviour. Journal of Nutrition 139: 623–628.

    Article  Google Scholar 

  46. Halpern, J.H., et al. 2005. Psychological and cognitive effects of long term peyote use among Native Americans. Biological Psychiatry 58: 624–631.

    Article  Google Scholar 

  47. Singer, T., H.D. Critchley, and K. Preuschoff. 2009. A common role for the insula in feelings, empathy and uncertainty. Trends in Cognitive Sciences 13: 334–340.

    Google Scholar 

  48. Craig, A.D. 2009. How do you feel—now? The anterior insula and human consciousness. Nature Reviews Neuroscience 10: 59–70.

    Article  Google Scholar 

  49. Craig, A.D. 2004. Human feelings: why are some more aware than others? Trends in Cognitive Sciences 8: 239–241.

    Article  Google Scholar 

  50. Craig, A.D. 2003. Interoception: the sense of the physiological condition of the body. Current Opinion in Neurobiology 13: 500–505.

    Article  Google Scholar 

  51. Craig, A.D. 2002. How do you feel? Interoception: the sense of the physiological condition of the body. Nature Reviews Neuroscience 3: 655–666.

    Google Scholar 

  52. Franklin, T., et al. 2002. Decreased grey matter concentration in the insular, orbitofrontal, cingulated and temporal cortices of cocaine patients. Biological Psychiatry 51: 134–142.

    Article  Google Scholar 

  53. Lubman, D.L., M. Yucel, and C. Pantelis. 2004. Addiction, a condition of compulsive behaviour? Neuroimaging and neuropsychological evidence of inhibitory dysregulation. Addiction 99: 1491–1502.

    Article  Google Scholar 

  54. Zombeck, J.A., et al. 2008. Neuroanatomical specificity of conditioned responses to cocaine versus food in mice. Physiology & Behavior 93: 637–650.

    Google Scholar 

  55. Mayfield, R.D., R.A. Harris, and M.A. Schuckit. 2008. Genetic factors influencing alcohol dependence. British Journal of Pharmacology 154: 275–287.

    Article  Google Scholar 

  56. Nader, M.A., et al. 2008. Positron emission tomography imaging studies of dopamine receptors in primate models of addiction. Philosophical Transactions of the Royal Society. Series B 363: 3223–3232.

    Article  Google Scholar 

  57. O’Brien, C.P. 2008. Evidence-based treatments of addiction. Philosophical Transactions of the Royal Society. Series B 363: 3277–3286.

    Article  Google Scholar 

  58. Beveridge, T.J.R., et al. 2008. Parallel studies of cocaine-related neural and cognitive impairment in humans and monkeys. Philosphical Transactions of the Royal Society. Series B 363: 3257–3266.

    Article  Google Scholar 

  59. Heberlein, U., et al. 2008. Drosophila, a genetic model system to study cocaine-related behaviours: a review with focus on LIM-only proteins. Neuropharmacology. doi:10.1016/jneuropharm.2009.07.023.

    Google Scholar 

  60. Squeglia, L.M., J. Jacobus, and S.F. Tapert. 2009. The influence of substance use on adolescent brain development. Clinical EEG & Neuroscience 40: 31–38.

    Google Scholar 

  61. McQuown, S.C., et al. 2009. Age-dependent effects of low-dose nicotine treatment on cocaine-induced behavioural plasticity in rats. Psychopharmacology 207: 143–152.

    Article  Google Scholar 

  62. Kirisci, L., et al. 2006. Individual differences in childhood neurobehaviour disinhibition predict decision to desist substance use during adolescence and substance use disorder in young adulthood: a prospective study. Addictive Behaviors 31: 686–695.

    Article  Google Scholar 

  63. Moolchan, E.T., and R. Mermelstein. 2002. Research on tobacco use among teenagers: ethical challenges. Journal of Adolescent Health 30: 409–417.

    Article  Google Scholar 

  64. Gulick, D., and T.J. Gould. 2008. Interactive effects of ethanol and nicotine on learning in C57BL/6 J mice depend on both dose and duration of treatment. Psychopharmacology 196: 483–495.

    Article  Google Scholar 

  65. Crabbe, J.C. 2008. Neurogenetic studies of alcohol addiction. Philosophical Transactions of the Royal Society. Series B 363: 3201–3211.

    Article  Google Scholar 

  66. Le Merrer, J., et al. 2009. Reward processing by the opioid system in the brain. Physiological Review 89: 1379–1412.

    Article  Google Scholar 

  67. Montoya, I.D., and F. Vocci. 2008. Novel medications to treat addictive disorders. Current Psychiatry Reports 10: 392–398.

    Article  Google Scholar 

  68. Rahman, S. 2008. Editorial: hot topic, drug addiction and brain targets, from preclinical research to pharmacotherapy. CNS & Neurological Disorders—Drug Targets 7: 391–392.

    Article  Google Scholar 

  69. Hall, W. 2005. Will nicotine genetics and a nicotine vaccine prevent cigarette smoking and smoking-related diseases? PLoS Medicine 2: 860–863.

    Article  Google Scholar 

  70. Wong, C.C.Y., and G. Schumann. 2008. Genetics of addictions: strategies for addressing heterogeneity and polygenicity of substance use disorders. Philosophical transactions of the Royal Society. Series B 363: 3213–3222.

    Article  Google Scholar 

  71. Lawrence, A.J., P.M. Beart, and P.W. Kalivas. 2008. Neuropharmacology of addiction: setting the scene. British Journal of Pharmacology 154: 259–260.

    Google Scholar 

  72. Kalivas, P.W. 2007. Neurobiology of cocaine addiction: implications for new pharmacotherapy. American Journal of Addiction 16: 71–78.

    Article  Google Scholar 

  73. Kalivas, P.W. 2009. Glutamate transmission in addiction. Neuropharmacology 56: 169–173.

    Article  Google Scholar 

  74. Fox, H.C., E.D. Jackson, and R. Sinha. 2009. Elevated cortisol and learning and memory deficits in cocaine dependent individuals: relationship to relapse outcomes. Psychoneuroendocrininology 34: 1198–1207.

    Article  Google Scholar 

  75. Imordino-Yang, M.H., and A. Damasio. 2007. We feel, therefore we learn: the relevance of affective and social neuroscience to education. Journal of Compilation 1: 3–10.

    Google Scholar 

  76. Wittmann, B.C., et al. 2008. Mesolimbic interaction of emotional valence and reward improves memory formation. Neuropsychologia 46: 1000–1008.

    Article  Google Scholar 

  77. Grant, J.E., and S.W. Kim. 2006. Medication management of pathological gambling. Minnesota Medicine http://www.minnesoatamedicine.com/PastIssues/September2006/ClinicalGrantSeptember Accessed 3 November 2009.

  78. Berkus, E. 2007. The link between psychotic disorders and substance use. Psychiatric Times 24 http://www.psychiatrictimes.com/print/article/10168/46501?printable=true. Accessed 3 November 2009.

  79. Ross, S., and E. Peselow. 2009. The neurobiology of addictive disorders. Clinical Neuropharmacology 32: 269–276.

    Article  Google Scholar 

  80. O’Connor, M.-F., et al. 2008. Craving love? Enduring grief activates brain’s reward center. Neuroimage 42: 969–972.

    Article  Google Scholar 

  81. Solinas, M., S.K. Goldberg, and D. Piomelli. 2008. The endocannibinoid system in brain reward processes. British Journal of Pharmacology 154: 369–383.

    Article  Google Scholar 

  82. Le Foll, B., D.A. Gorelick, and S.R. Goldberg. 2009. The future of endocannabinoid oriented clinical research after CB1 antagonists. Psychopharmacology 205: 1506–1507.

    Article  Google Scholar 

  83. Corrigall, W.A. 2009. Hypocretin mechanisms in nicotine addiction: evidence and speculation. Psychopharmacology 206: 23–37.

    Article  Google Scholar 

  84. Gullo, M.J., and S. Dawe. 2008. Impulsivity and adolescent substance use: rashly dismissed as all bad? Neuroscience and Biobehavioral Reviews 32: 1507–1518.

    Article  Google Scholar 

  85. Naqvi, N.H., and A. Bechara. 2008. The hidden island of addiction: the insula. Trends in Neuroscience 32: 56–67.

    Article  Google Scholar 

  86. Domschke, K., et al. 2009. Interioceptive sensitivity to anxiety and anxiety disorders: an overview and integration of neurobiological findings. Clinical Psychology Review. doi:10.1016/.cpr.2009.08.008.

    Google Scholar 

  87. Koob, G.F. 2009. Dynamics of neuronal circuits in addiction: reward, anti-reward and emotional memory. Pharmacopsychiatry 42: 532–541.

    Google Scholar 

  88. Evers, K. 2007. Perspectives on memory manipulation: using beta-blockers to cure post-traumatic stress disorder. Cambridge Quarterly of Healthcare Ethics 16: 138–146.

    Article  Google Scholar 

  89. Boutrel, B. 2008. A neuropeptide-centric view of psychostimulant addiction. British Journal of Pharmacology 154: 343–357.

    Article  Google Scholar 

  90. Fudala, P.J., and R.E. Johnson. 2006. Development of opioid formulations with limited diversion and abuse potential. Drug and Alcohol Dependence 83: S40–S47.

    Article  Google Scholar 

  91. Mitchell, J.M., et al. 2009. Natrexone aversion and treatment efficacy are greatest in humans and rats that actively consume high levels of alcohol. Neurobiology of Disease 33: 72–80.

    Article  Google Scholar 

  92. Maas, U., and S. Strubelt. 2006. Fatalities after taking ibogaine in addiction treatment could be related to sudden cardiac death caused by autonomic dysfunction. Medical Hypotheses 67: 960–964.

    Article  Google Scholar 

  93. Alper, K., and H. Lotsof. 1999. Treatment of acute opiod withdrawal with ibogaine. American Journal of Addiction 8: 234–242.

    Article  Google Scholar 

  94. Mackenzie, R. 2009. Reframing the good death: enhancing choice in dying, neuroscience, end of life research and the potential of psychedelics in palliative care. In Law, Mind and Brain, ed. M. Freeman and O. Goodenough, 239–263. London: Ashgate.

    Google Scholar 

  95. Garavan, H., J.N. Kaufman, and R. Hester. 2008. Acute effects of cocaine on the neurobiology of cognitive control. Philosophical Transactions of the Royal Society. Series B 363: 3267–3276.

    Article  Google Scholar 

  96. McGregor, I.S., P.D. Callaghan, and G.E. Hunt. 2008. From ultrasocial to antisocial: a role for oxytocin in the acute reinforcing effects and long term adverse consequences of drug use? British Journal of Pharmacology 154: 358–368.

    Article  Google Scholar 

  97. Johnson, M.W., W.A. Richards, and R.R. Griffiths. 2008. Human hallucinogen research: guidelines for safety. Journal of Psychopharmacology 22: 603–620.

    Google Scholar 

  98. Santos, R.G., et al. 2007. Effects of ayahuasca on psychometric measures of anxiety, panic-like and hopelessness in Santo Daime members. Journal of Ethnopharmacology 112: 507–513.

    Article  Google Scholar 

  99. Hall, W., MacDonald Christie, and D. Currow. 2005. Cannabinoids and cancer: causation, remediation and palliation. Lancet Oncology 6: 35–42.

    Google Scholar 

  100. Burns, K., and A. Bechara. 2007. Decision making and free will: a neuroscience perspective. Behavioral Sciences and the Law 25: 263–280.

    Article  Google Scholar 

  101. Northoff, G. 2006. Neuroscience of decision making and informed consent: an investigation in neuroethics. Journal of Medical Ethics 32: 70–73.

    Article  Google Scholar 

  102. Vengeliene, V., et al. 2008. Neuropharmacology of alcohol addiction. British Journal of Pharmacology 154: 299–315.

    Article  Google Scholar 

  103. Bechara, A., and H. Damasio. 2002. Decision-making and addiction (part I): impaired activation of somatic states in substance dependent individuals when pondering decisions with negative future consequences. Neuropsychologia 40: 1675–1689.

    Article  Google Scholar 

  104. Bechara, A., S. Dolan, and A. Hines. 2002. Decision-making and addiction (part II): myopia for the future or hypersensitivity to reward? Neuropsychologia 40: 1696–1705.

    Google Scholar 

  105. Mackenzie, R., and M. Sakel. 2010. The neuroscience of cruelty as brain damage: legal framings of capacity and ethical issues in the neurorehabilitation of motor neurone disease and behavioural variant fronto-temporal dementia patients. In Law and neuroscience: current legal issues, ed. M. Freeman. Oxford: Oxford University Press.

    Google Scholar 

  106. Mackenzie, R., and J. Watts. 2009. Callous/unemotional conduct disorder as a learning disability. Tizard Learning Disability Review 14: 38–44.

    Google Scholar 

  107. Verdejo-Garcia, A., and A. Bechara. 2008. A somatic marker theory of addiction. Neuropharmacology 56: 48–62.

    Article  Google Scholar 

  108. Jeste, D.V., and E. Saks. 2006. Decisional capacity in mental illness and substance use disorders: empirical database and policy implications. Behavioral Sciences and the Law 24: 607–628.

    Article  Google Scholar 

  109. Gray, M.A., and H.D. Critchley. 2007. Interoceptive basis to craving. Neuron 54: 183–186.

    Article  Google Scholar 

  110. Paulus, M.P., S.F. Tapert, and G. Schulteis. 2009. The role of interoception and alliesthesia in addiction. Pharmacology, Biochemistry and Behavior 94: 1–7.

    Article  Google Scholar 

  111. Goldstein, R., et al. 2009. The neurocircuitry of impaired insight in drug addiction. Trends in Cognitive Science 13: 372–380.

    Article  Google Scholar 

  112. Gray, M.T. 2005. The shifting sands of self: a framework for the experience of self in addiction. Nursing Philosophy 6: 119–130.

    Article  Google Scholar 

  113. Shinebourne, P., and J.A. Smith. 2009. Alcohol and the self: an interpretative phenomenological analysis of the experience of addiction and its impact on the sense of self and society. Addiction Research & Theory 17: 152–167.

    Article  Google Scholar 

  114. Baler, R.D., and N.D. Volkow. 2006. Drug addiction: the neurobiology of disrupted self-control. Trends in Molecular Medicine 12: 559–566.

    Article  Google Scholar 

  115. Folini, C., and E. Racine. 2009. Disagreements with implications: diverging discourses on the ethics of non-medical use of methylphenidate for performance enhancement. BMC Medical Ethics 10: 9–19.

    Article  Google Scholar 

  116. Forstl, H. 2009. Neuro-enhancement: brain doping. Nervenarzt 7: 840–846.

    Article  Google Scholar 

  117. Lenzken, L.C., et al. 2008. Cognition enhancers: between treating the body and doping the mind. Pharmacological Research 57: 196–213.

    Article  Google Scholar 

  118. Soyka, M. 2009. Neuro-enhancement from an addiction specialist’s viewpoint. Nervenarzt 80: 837–839.

    Article  Google Scholar 

  119. Wolpe, P.R. 2002. Treatment, enhancement and the ethics of neurotherapeutics. Brain & Cognition 50: 387–395.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Kent Law School, Eliot College, University of Kent, Canterbury, Kent, CT2 7NY, UK

    Robin Mackenzie

Authors
  1. Robin Mackenzie
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Robin Mackenzie.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Mackenzie, R. The Neuroethics of Pleasure and Addiction in Public Health Strategies Moving Beyond Harm Reduction: Funding the Creation of Non-Addictive Drugs and Taxonomies of Pleasure. Neuroethics 4, 103–117 (2011). https://doi.org/10.1007/s12152-010-9074-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12152-010-9074-4

Keywords

  • Addiction
  • Designer drugs
  • Harm reduction
  • Pleasure
  • Public health